 Skye Bioscience Inc OTCQB:SKYE and Emerald Health Therapeutics Inc said they have entered into a definitive agreement that will see Skye acquiring Emerald in a share-for-share transaction. Under the proposed plan of arrangement, Skye will issue Emerald shareholders 1.95 shares of its shares in exchange for each Emerald share, resulting in current Skye stockholders owning approximately 54 of its common stock and former shareholders of Emerald owning approximately 46. 